Kamen and Sequel Medtech CEO Alan Lotvin say they are offering greater precision in insulin delivery with new pump technology ...

CGMs are wearable devices that are applied ... Both Dexcom systems can be programmed to work with insulin pumps, whereas only ...

CGMs can be used for patients on insulin injections or insulin pump therapy for Type 1 or Type 2 diabetes. They are available either for personal use or for diagnostic use* by healthcare ...

With an increasing burden of diabetes in Singapore, digital innovations, research can help diabetics manage better. Read more ...

Lilly has taken a non-exclusive license to deploy Dexcom’s CGM systems – which include app-based remote monitoring and alarm functions – in pen- and pump-based insulin systems that form the ...

Insulin pump therapy, also known as continuous subcutaneous insulin infusion (CSII), is an important and evolving form of insulin delivery, which is mainly used for people with type 1 diabetes.

Modern insulin pumps are self-contained devices that attach to a user’s skin via an adhesive patch, and are responsible for administering insulin as needed. Curious as to what was inside ...

Almost 1,000 people with diabetes in Lothian are on a waiting list for access to technology which could change their lives, ...

Insulet has launched the Omnipod 5 automated insulin delivery app for iPhone in the US. The app obviates the need for ...